Coenzyme Q10 in Older Athletes Treated With Statin Medications

Completed · Phase 4 · Has a placebo group

Conditions studied: Muscle Weakness, Myalgia, Side Effects of Statins

In brief

The purpose of this study is to evaluate the effect of coenzyme Q10 administration in improving mitochondrial function as measured by anaerobic threshold in older athletes on a stable dose of statin medication.

Key facts

Study ID

NCT01026311

Run by

Richard Deichmann, MD

People needed

20

Starts

2009-11-01

Expected to finish

2011-03-01

Last updated by the study team

2012-05-03

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients ≥ 50 years of age, male or female.
• Patients on a stable dose of statin medication for at least 3 months prior to enrollment in the study
• Self-Described Athletes with any of the following characteristics:
• Participation in a competitive athletic event within the past year or currently training for a competitive athletic event within the 6 months following enrollment
• Regular exercise activity of at least 45 minutes duration 5 times per week

You may not qualify if…

• Use of coenzyme Q10 during the preceding two months.
• CPK level at baseline greater than two times the upper limits of normal
• LDL level at baseline greater than 160 for those without a cardiovascular risk or cardiovascular risk equivalent
• LDL level at baseline greater than 130 for those with a cardiovascular risk or cardiovascular risk equivalent

Where it is running

• Ochsner — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.